A breast cancer rash can look like a harmless skin irritation—but there’s a notable difference. Cancer doctors explain why it ...

When it comes to red flags around breast cancer, most women know that feeling a new lump in your breast is a reason to seek medical attention immediately. But as it turns out, a rash is also something ...

Most of us know that if we notice a lump in our breast, we need to get examined by a doctor in case it’s cancerous. But it turns out we should also be on the lookout for a rash on the breast. That’s ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Please provide your email address to receive an email when new articles are posted on . ATR-04 has received a fast track designation from the FDA for epidermal growth factor receptor ...

Cancer therapies can cause significant skin, scalp, and nail side effects in nearly two-thirds of patients, impacting comfort and confidence. Oncodermatology, a specialized field, aims to manage these ...

A research team from the UCLA Health Jonsson Comprehensive Cancer Center, the University of Texas MD Anderson Cancer Center, and collaborators have demonstrated that a novel topical BRAF inhibitor gel ...

ATR04-484 is a live biotherapeutic product targeting EGFR inhibitor-associated rashes in cancer patients, containing a modified Staphylococcus epidermidis strain. EGFR inhibitors, used in treating ...

LUT014 gel significantly reduces acne-like rashes from anti-EGFR therapies in colorectal cancer patients, improving quality of life. The phase 2 trial showed 70% improvement with high-dose gel, ...

Skin conditions like psoriasis and eczema can have rashes that are difficult to distinguish by eye. tylim/iStock via Getty Images Plus Rashes can be thought of as a dysfunctional community of skin ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...